Dan Theodorescu awarded Barringer Medal for distinguished contributions to urology

Dan Theodorescu, MD, PhD, director of the NCI-designated University of Colorado Cancer Center and professor of Urology and Pharmacology at the University of Colorado School of Medicine was awarded the Barringer Medal this spent Saturday from the American Association of Genitourinary Surgeons towards his distinguished contributions to urology.

“I am honored across measure to receive this award from every institution that I greatly respect and be astonished,” Theodorescu says.

Every year, the Barringer Medal is awarded to a urologic surgeon toward outstanding contributions to the field. The before anything else award in 1955 went to Charles Huggins, the single urologist to ever have won a Nobel Prize, toward his discovery of the hormonal sensitivity of tumors. Traditionally, the heinous-tie award presentation opens with pictures of the receiver as a child.

“I was surprised at the time I recognized myself in the foremost picture!” says Theodorescu, though he mentions he cast it a bit suspicious when his wife, who was company to the surprise, insisted on joining him in San Francisco conducive to this year’s annual meeting.

Related Stories

“I’m provident, so usually I skip the fiendish tie event, but this year I had to rectify other travel plans to include it because Diane wanted to attend,” he says. “I find out she and the awards committee had been plotting this with regard to months…”

Dr. Theodorescu is an internationally recognized clever in the biology and treatment of bladder cancer. In joining to directing the CU Cancer Center, Theodorescu manages one active translational molecular biology lab focused steady identifying the mechanisms leading to bladder cancer advancement and spread and their potential applications to patients through this disease.

Theodorescu has been involved in the progressive growth and testing of COXEN (CO-eXpression ExtrapolatioN), a simple new personalized medicine strategy that aims to predict which tumors will be sensitive to what one. drugs based on genetic analysis of tumefaction samples. He also led the team that in 2014 described the pristine drug against Ral, an oncogene that contributes to urge several cancer types including pancreas, lung, colon, bladder and prostate.

Created in 1954, the decree honors Benjamin S. Barringer, the in the beginning chief of urology at what is things being so the Memorial Sloan Kettering Cancer Center in New York City. Barringer was each early innovator of brachytherapy in 1915, in that radium needles were used to negotiate prostate cancer.

“I see the adjudication not as a pat on the back yet as incentive to work even harder in a state of preparation understanding the causes and best treatments in favor of cancer, which has been my pupilage dream,” Theodorescu says.


University of Colorado Denver

B12- this vitamin enhances muscle nervous diction, provides endowment and helps your nerves office properly.

Recent Comments